Literature DB >> 20526950

The association between serotonin transporter gene promotor polymorphism (5-HTTLPR) and elemental mercury exposure on mood and behavior in humans.

Diana Echeverria1, James S Woods, Nicholas J Heyer, Michael D Martin, Dianne S Rohlman, Federico M Farin, Tingting Li.   

Abstract

A functional polymorphism in the serotonin transporter (5-HTT) gene-linked polymorphic region (5-HTTLPR) is reported to affect mood and behavior in humans. In this study, the effects of 5-HTTLPR polymorphism on neurobehavioral and mood domains that are known to be affected by elemental mercury (Hg degrees ) exposure in human subjects were examined. The Behavioral Evaluation for Epidemiologic Studies (BEES) test battery was administered concurrently with urine and buccal-cell collections for 164 male dentists (DD) and 101 female dental assistants (DA) with occupational exposure to Hg degrees for an average of 19 and 10 yr, respectively. Geometric mean urinary mercury (Hg) levels in DD and DA were 2.52 (2.22) microg/L and 1.98 (1.98) microg/L, respectively. Corresponding indices of chronic occupational Hg degrees exposure, weighted for historical exposure, were 1212 (1877) and 316 (429). 5-HTTLPR status was 40% and 20% wild type, 40% and 56% single allelic substitution, and 20% and 24% double allelic substitution for the two genders. DD and DA were evaluated separately. Regression analyses controlled for age, premorbid intelligence, frequency of alcohol per week, and education. 5-HTTLPR polymorphism was associated with 5 behavioral measures in DD and with 12 behavioral measures in DA. Mood scores were more consistently associated with the variant in both groups. The strongest evidence for an additive effect for urinary Hg and 5-HTTLPR polymorphism in both groups was for tests of Finger Tap(Alternate) and Hand Steadiness(Factor1). Other significant additive effects that were less consistent across groups were also observed. These results add to the growing evidence of genetic determinants of mood and behavior that potentially increase susceptibility to Hg toxicity in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20526950      PMCID: PMC2882654          DOI: 10.1080/15287390903566591

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  38 in total

1.  Health and neuropsychological functioning of dentists exposed to mercury.

Authors:  K A Ritchie; W H Gilmour; E B Macdonald; F J T Burke; D A McGowan; I M Dale; R Hammersley; R M Hamilton; V Binnie; D Collington
Journal:  Occup Environ Med       Date:  2002-05       Impact factor: 4.402

2.  Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.

Authors:  S D Pingree; P L Simmonds; J S Woods
Journal:  Toxicol Sci       Date:  2001-06       Impact factor: 4.849

3.  Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.

Authors:  B G Pollock; R E Ferrell; B H Mulsant; S Mazumdar; M Miller; R A Sweet; S Davis; M A Kirshner; P R Houck; J A Stack; C F Reynolds; D J Kupfer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

4.  Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression.

Authors:  K P Lesch; S Jatzke; J Meyer; G Stöber; O Okladnova; R Mössner; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

5.  Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

Authors:  Keizo Yoshida; Kenichi Ito; Kazuhiro Sato; Hitoshi Takahashi; Mitsuhiro Kamata; Hisashi Higuchi; Tetsuo Shimizu; Kunihiko Itoh; Kazuyuki Inoue; Takehiko Tezuka; Toshio Suzuki; Tadashi Ohkubo; Kazunobu Sugawara; Koichi Otani
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-02       Impact factor: 5.067

6.  Serotonin transporter gene polymorphism and antidepressant response.

Authors:  D K Kim; S W Lim; S Lee; S E Sohn; S Kim; C G Hahn; B J Carroll
Journal:  Neuroreport       Date:  2000-01-17       Impact factor: 1.837

7.  Attempted suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia.

Authors:  S A Chong; W L Lee; C H Tan; A H Tay; A O Chan; E C Tan
Journal:  Psychiatry Res       Date:  2000-12-27       Impact factor: 3.222

8.  A gender-specific association between the serotonin transporter gene and suicide attempts.

Authors:  Enrique Baca-García; Concepción Vaquero; Carmen Diaz-Sastre; Jeronimo Saiz-Ruiz; José Fernández-Piqueras; Jose de Leon
Journal:  Neuropsychopharmacology       Date:  2002-05       Impact factor: 7.853

9.  Catechol O-methyltransferase (COMT) VAL158MET functional polymorphism, dental mercury exposure, and self-reported symptoms and mood.

Authors:  Nicholas J Heyer; Diana Echeverria; Michael D Martin; Federico M Farin; James S Woods
Journal:  J Toxicol Environ Health A       Date:  2009

Review 10.  The three modern faces of mercury.

Authors:  Thomas W Clarkson
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

View more
  10 in total

1.  Low-level mercury, omega-3 index and neurobehavioral outcomes in an adult US coastal population.

Authors:  Caterina Vacchi-Suzzi; Roxanne Karimi; Danielle Kruse; Susan M Silbernagel; Keith E Levine; Diane S Rohlman; Jaymie R Meliker
Journal:  Eur J Nutr       Date:  2015-04-02       Impact factor: 5.614

2.  Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children.

Authors:  James S Woods; Nicholas J Heyer; Diana Echeverria; Joan E Russo; Michael D Martin; Mario F Bernardo; Henrique S Luis; Lurdes Vaz; Federico M Farin
Journal:  Neurotoxicol Teratol       Date:  2012-07-02       Impact factor: 3.763

3.  Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: summary findings from the Casa Pia Children's Amalgam clinical trial.

Authors:  James S Woods; Nicholas J Heyer; Joan E Russo; Michael D Martin; Federico M Farin
Journal:  Neurotoxicology       Date:  2014-08-07       Impact factor: 4.294

Review 4.  Effect of Gene-Mercury Interactions on Mercury Toxicokinetics and Neurotoxicity.

Authors:  Sabrina Llop; Ferran Ballester; Karin Broberg
Journal:  Curr Environ Health Rep       Date:  2015-06

5.  Urinary porphyrin excretion in neurotypical and autistic children.

Authors:  James S Woods; Sarah E Armel; Denise I Fulton; Jason Allen; Kristine Wessels; P Lynne Simmonds; Doreen Granpeesheh; Elizabeth Mumper; J Jeffrey Bradstreet; Diana Echeverria; Nicholas J Heyer; James P K Rooney
Journal:  Environ Health Perspect       Date:  2010-06-24       Impact factor: 9.031

Review 6.  Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.

Authors:  José G Dórea
Journal:  Neurochem Res       Date:  2011-02-25       Impact factor: 4.414

Review 7.  Genetic Aspects of Susceptibility to Mercury Toxicity: An Overview.

Authors:  Virginia Andreoli; Francesca Sprovieri
Journal:  Int J Environ Res Public Health       Date:  2017-01-18       Impact factor: 3.390

8.  Perception and Knowledge of Mercury by Occupationally Exposed Health Care Personnel.

Authors:  Isabel Álvarez-Solorza; Luz D Upegui-Arango; Víctor Borja-Aburto; Norma González-González; Felix Fischer; L Patricia Bustamante-Montes
Journal:  J Contin Educ Health Prof       Date:  2022-01-01       Impact factor: 2.190

9.  Genetic susceptibility to methylmercury developmental neurotoxicity matters.

Authors:  Jordi Julvez; Philippe Grandjean
Journal:  Front Genet       Date:  2013-12-13       Impact factor: 4.599

10.  Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.

Authors:  Cassianne Robinson-Cohen; Richard Newitt; Danny D Shen; Allan E Rettie; Bryan R Kestenbaum; Jonathan Himmelfarb; Catherine K Yeung
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.